X.T.L. Biopharmaceuticals Ltd. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| RHUMBLINE ADVISERS | 08/12/2026 | 6.23 K | $17.00 K | 4.03% | 1.48% |
| GAMMA INVESTING LLC | 07/07/2026 | 1.21 K | $3.31 K | -64.20% | 0.29% |
| UBS GROUP AG | 08/13/2026 | 125 | $341 | 100.00% | 0.03% |
| MORGAN STANLEY | 08/13/2026 | 0 | $0 | -100.00% | 0.00% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 08/11/2026 | 0 | $0 | -100.00% | 0.00% |
| NOKED ISRAEL LTD | 08/13/2026 | 0 | $0 | -100.00% | 0.00% |
| SMARTHARVEST PORTFOLIOS, LLC | 08/04/2026 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
X.T.L. Biopharmaceuticals Ltd. institutional Ownership - FAQ's
During the previous two years, 8 institutional investors and hedge funds held shares of X.T.L. Biopharmaceuticals Ltd.. The most heavily invested institutionals were:
RHUMBLINE ADVISERS: 6,228
GAMMA Investing LLC: 1,213
UBS Group AG: 125
MORGAN STANLEY: 0
SmartHarvest Portfolios, LLC: 0
Noked Israel Ltd: 0
1.80% of X.T.L. Biopharmaceuticals Ltd. stock is owned by institutional investors.
Institutional investors have bought a total of 206.45 K shares in the last 24 months. This purchase volume represents approximately $144.52 K in transactions.